Clinical trials
Disease clinical trials
Below are recruiting disease clinical trials, each written for real people, not researchers. We’re tracking 9,359 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07588295Recruiting
How immune cells respond in heart and leg blood vessel disease
This study examines how immune cells (macrophages) behave differently in patients with blocked arteries in the heart or legs. Understanding this may help doctors develop better treatments for these conditions.
Cotignola, RavennaAges 18 years+ - NCT06720870Recruiting
Siltuximab for Castleman's disease: a real-world study
This trial is looking back at the medical records of people with a rare condition called Castleman's disease to see how well the drug Siltuximab worked for them in everyday hospital care, not in a research setting. The goal is to learn more about how safe and effective the drug can be for patients in real life.
Bologna, BolognaAges 18 years+ - NCT06721767Recruiting
IBD monitoring study at a regional center
This trial is a monitoring study for people with inflammatory bowel diseases (IBD), such as Crohn's disease or ulcerative colitis. It aims to follow patients who have been seen at a specialized IBD center to gather information and improve care.
BolognaAges 14 years+ - NCT05939999Recruiting
Elastic tape plus rehab for COPD breathing problems
This trial studies whether using elastic tape during pulmonary rehabilitation can improve breathing and physical function in people with moderate to very severe COPD. It may help you tolerate rehab exercises more comfortably if you meet their specific health and safety requirements.
São Paulo, São PauloAges Any age - NCT07581834RecruitingPhase 2
Dalpiciclib plus hormone therapy for early hormone-positive breast cancer
This study tests whether adding a new drug called dalpiciclib to standard hormone therapy improves outcomes for women with early-stage breast cancer that is hormone-receptor positive. The goal is to see if this combination is more effective and safe than hormone therapy alone.
Fuzhou, FujianAges 18 years+ - NCT07577843RecruitingPhase 3
Testing JNJ-78934804 for moderate to severe Crohn's disease
This study tests a new drug called JNJ-78934804 for people with moderate to severe Crohn's disease who have not responded well to or can't tolerate current treatments. The goal is to see if this drug can reduce inflammation and symptoms in the digestive tract.
Anaheim, CaliforniaAges 18 years+ - NCT07585669Recruiting
Omega-3 Supplements for New Celiac Disease Patients
This study tests whether omega-3 fatty acids (a type of fish oil supplement) can reduce inflammation and improve gut health in people newly diagnosed with celiac disease. Participants will follow a gluten-free diet while taking the supplement to see if it helps their body heal.
Santiago, Metropolitan RegionAges 18–65 - NCT07578090Recruiting
Managing high blood pressure, blood sugar, and cholesterol
This study tests a new approach to helping people manage chronic conditions like high blood pressure, high blood sugar, or high cholesterol. Researchers will work with participants to improve their care and quality of life.
New Taipei CityAges 18 years+ - NCT07577609Recruiting
AI-assisted CT scan to assess heart artery disease risk
This study uses artificial intelligence to analyze your heart CT scan and better predict your risk of coronary artery disease (narrowing of the arteries that supply your heart). The goal is to help doctors identify who might need earlier treatment or more careful monitoring.
GalwayAges 18 years+ - NCT07582861Recruiting
Support for Mothers Expecting Babies With Heart Disease
This study offers psychological support to pregnant mothers who have learned their baby has congenital heart disease (a heart condition present at birth). The research tests whether counseling and coping strategies provided before and after birth can help mothers manage stress and anxiety during this challenging time.
Phoenix, ArizonaAges 18 years+ - NCT07585409Recruiting
Physical Activity for Parkinson's Disease Patients
This study tests whether physical activity (like exercise or movement) can help people with Parkinson's disease feel better and move more easily. Researchers want to understand how activity affects Parkinson's symptoms and quality of life.
StockholmAges 18 years+ - NCT07585175Recruiting
Moving from pediatric to adult heart disease care
This study helps doctors understand how to smoothly transition young people with heart problems they were born with from pediatric (children's) hospitals to adult care. It may help improve care coordination and outcomes as patients grow up.
Ottawa, OntarioAges 18 years+ - NCT06723704Recruiting
Long-term outlook in adults with congenital heart disease
This study looks at how adults with congenital heart disease (a heart problem you were born with) do over time. By reviewing medical records, doctors hope to learn what affects long-term health and help improve care for patients like you.
Rome, RMAges 18 years+ - NCT07572071RecruitingPhase 1
Cell transplant study for moderate Parkinson's disease
This trial tests whether transplanting specially grown cells (DopaCell) into the brain can safely help people with moderate Parkinson's disease whose symptoms aren't well controlled by medication. The cells are intended to produce dopamine, the chemical that Parkinson's affects.
ShirazAges 30–70 - NCT07574879RecruitingPhase 1
H. pylori Treatment Effects on COPD Symptoms
This study tests whether treating a stomach bacteria infection (H. pylori) can improve breathing and lung function in people with COPD. Researchers want to see if eliminating this bacteria helps reduce COPD symptoms.
Zagazig, ElsharkiaAges 40 years+ - NCT07575997Recruiting
Testing Different Interdental Brushes for Gum Disease
This study compares different types of small brushes designed to clean between your teeth in adults with periodontal disease (a serious gum condition). The goal is to see which brush works best at improving gum health.
BrusselsAges 18–80 - NCT07571161RecruitingPhase 3
Donanemab for early Alzheimer's disease in Chinese participants
This trial tests a drug called donanemab in people who have early signs of Alzheimer's disease (amyloid buildup in the brain) but are still thinking clearly. The goal is to see if the drug can slow or prevent cognitive decline before memory problems start.
BeijingAges 55–80 - NCT05385315Recruiting
Blood test study to help detect Parkinson’s disease early
This study looks for a new blood marker that could help doctors detect Parkinson’s disease earlier. Depending on your diagnosis and treatment status, your blood may be compared with other people’s to see how well the test works.
GrenobleAges 18 years+ - NCT07570771Recruiting
Dialysis duration effects on bladder function in transplant candidates
This study examines how long you've been on dialysis and how much urine you still produce might affect your bladder's ability to hold and stretch after a kidney transplant. Understanding this helps doctors predict how well your bladder will work after you receive a new kidney.
Karachi, SindhAges 18–65 - NCT07570446Recruiting
Autonomic Function in Charcot-Marie-Tooth Disease
This study examines how autonomic nerves (the nerves that control automatic body functions like heart rate and blood pressure) are affected in people with CMT (Charcot-Marie-Tooth disease), a genetic nerve disorder. Understanding this may help improve treatment and quality of life for CMT patients.
Göttingen, Lower SaxonyAges 18–65 - NCT07570719Recruiting
Community screening for early Alzheimer's disease signs
This study screens people aged 60–80 for early signs of Alzheimer's disease in a community setting. Researchers will ask you questions and may perform brain imaging to understand who might benefit from early detection and treatment.
Shanghai, Shanghai MunicipalityAges 60–80 - NCT07569653RecruitingPhase 4
CMV Prevention After Stem Cell Transplant Using Blood Tests
This trial tests whether doctors can safely stop a CMV prevention medication (letermovir) earlier by using blood tests to check your immune system's strength. CMV is a virus that can become dangerous after stem cell transplant, and this study aims to prevent it while minimizing unnecessary medicine.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07569133Enrolling by invitation
Brain stimulation for depression in Parkinson's disease
This study tests whether a non-invasive brain stimulation treatment called repetitive transcranial magnetic stimulation (rTMS) can help improve depressive symptoms in people with Parkinson's disease. If you have Parkinson's and feel depressed, this treatment might be a new option for you.
Daegu, Buk-guAges 40–90 - NCT07569458Recruiting
Online therapy for heart disease patients with depression or anxiety
This trial tests an online program designed to help people with heart disease who are also experiencing depression or anxiety. The program is personalized to your needs and delivered through a computer or tablet over several weeks.
AalborgAges 18 years+
Hear when a new Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for disease?
- Yes. Clin2 currently lists 9,359 recruiting disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.